VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $73,799,500 | +184.6% | 2,575,000 | +139.5% | 0.60% | +79.6% |
| Q3 2022 | $25,929,000 | -3.0% | 1,075,000 | +10.2% | 0.33% | +57.1% |
| Q2 2022 | $26,718,000 | -64.7% | 975,804 | -50.6% | 0.21% | -7.8% |
| Q1 2022 | $75,772,000 | +142.4% | 1,975,804 | +102.5% | 0.23% | -72.3% |
| Q4 2021 | $31,255,000 | +8.7% | 975,804 | 0.0% | 0.83% | -17.4% |
| Q3 2021 | $28,757,000 | -67.1% | 975,804 | -62.1% | 1.00% | -72.2% |
| Q2 2021 | $87,526,000 | +176.0% | 2,575,804 | +164.0% | 3.61% | +219.0% |
| Q1 2021 | $31,714,000 | -65.8% | 975,804 | -62.1% | 1.13% | -64.1% |
| Q4 2020 | $92,780,000 | -42.2% | 2,575,804 | -37.1% | 3.16% | +55.1% |
| Q3 2020 | $160,391,000 | +142.9% | 4,095,804 | +127.5% | 2.04% | +10.1% |
| Q2 2020 | $66,024,000 | +147.2% | 1,800,000 | +80.0% | 1.85% | +204.4% |
| Q3 2019 | $26,710,000 | +48.3% | 1,000,000 | +24.5% | 0.61% | +15.4% |
| Q1 2019 | $18,014,000 | -84.5% | 803,500 | -85.5% | 0.53% | -83.5% |
| Q4 2018 | $116,491,000 | +682.8% | 5,523,500 | +587.4% | 3.19% | +652.4% |
| Q3 2018 | $14,881,000 | – | 803,500 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |